Press release
In-Depth Examination of Segments, Industry Developments, and Key Players in the Biologics Market
Biologics Market
Forecasted Growth and Market Size of the Biologics Industry
The biologics market is anticipated to expand significantly, reaching a valuation of $827.24 billion by 2030. This growth represents a compound annual growth rate (CAGR) of 11.2% during the forecast period. Several factors contribute to this upward trend including the development of novel monoclonal antibodies, the rise of mRNA and viral vector vaccines, and the growing use of personalized biologic therapies. Additional support stems from increased government funding and the integration of digital health platforms for patient monitoring. Trends driving market progression include the expanded use of monoclonal antibodies and therapeutic proteins, the surge in vaccine innovation, broader distribution through hospital pharmacies, and an intensified focus on personalized medicine and biologic treatments combined with advanced healthcare technologies.
Download a free sample of the biologics market sample:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3606&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Leading Players Influencing the Biologics Market Dynamics
The biologics market features a range of influential companies shaping its growth trajectory. Key players include Merck & Co. Inc., AbbVie Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Pfizer Inc., Bristol Myers Squibb Company, Sanofi S.A., GlaxoSmithKline Plc., Eli Lilly and Company, Amgen Inc., Shanghai Fosun Pharmaceuticals, Bayer AG, Novartis AG, and BiosanaPharma. Other notable contributors are WuXi, Teva UK Limited, AstraZeneca, Abbott Laboratories, Vectura Group, Fujifilm, Lonza, Seqens, Piramal Pharma Solutions, Corden Pharma, Procos SpA, BSP Pharmaceuticals, Microgen, Geropharm, Valenta, NovaMedica, SynBi, Rani Therapeutics, Enteris BioPharma, Allena Pharmaceuticals, Biogen Inc., Emisphere Technologies Inc., Apotex, and Gilead Sciences.
Recent Strategic Acquisitions Enhancing Market Reach
In October 2025, Terumo Corporation, a healthcare technology firm based in Japan, completed the acquisition of WuXi Biologics' drug-product manufacturing facility and quality-control lab in Leverkusen, Germany. Although the financial details were not disclosed, this purchase is intended to broaden Terumo's contract development and manufacturing organization (CDMO) presence in Europe. Furthermore, it strengthens their integrated injectable therapeutics services and boosts global responsiveness for biopharmaceutical clients. WuXi Biologics GmbH specializes in biopharmaceutical contract development and manufacturing services specifically for biologics and advanced therapies, making this acquisition strategically valuable for Terumo.
View the full biologics market report:
https://www.thebusinessresearchcompany.com/report/biologics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Emerging Trends Highlighting Innovations in the Biologics Space
Companies in the biologics sector are increasingly developing biosimilars to offer more affordable alternatives to existing biologic therapies. Biosimilars are highly similar to approved reference biologics with no meaningful differences in safety, efficacy, or quality, helping reduce treatment costs and improve patient access to advanced medicines.
A notable example is the July 2025 launch by Biocon Biologics, a subsidiary of India's Biocon Limited. They introduced Nepexto in Australia, a biosimilar version of Enbrel (etanercept). Nepexto is a fusion-protein biologic that targets tumor necrosis factor-alpha (TNF-a), a key inflammatory agent in autoimmune diseases. It mimics the activity of the original etanercept molecule, providing comparable safety and effectiveness. Supported by extensive clinical data and regulatory approvals, Nepexto is positioned as a strong treatment choice for conditions including rheumatoid arthritis, psoriasis, and ankylosing spondylitis. The product is further backed by an established supply chain through its local partner, Generic Health, enhancing accessibility for long-term disease management.
Segment Overview and Classification Within the Biologics Market
This report breaks down the biologics market into several key segments:
1) By Type: Monoclonal Antibodies (MAbs), Therapeutic Proteins, Vaccines
2) By Drug Classification: Branded Drugs, Generic Drugs
3) By Route of Administration: Oral, Other Routes
4) By Mode of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies or Drug Stores, Other Channels
Further subcategories delve deeper:
- Monoclonal Antibodies include Naked, Conjugated, and Bispecific MAbs
- Therapeutic Proteins are subdivided into Hormones, Enzymes, Cytokines, and Fusion Proteins
- Vaccine types include Live Attenuated, Inactivated, Subunit, mRNA, and Viral Vector Vaccines
These categories reflect the diverse range of biologic products and distribution methods shaping this expansive market.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release In-Depth Examination of Segments, Industry Developments, and Key Players in the Biologics Market here
News-ID: 4495370 • Views: …
More Releases from The Business Research Company
Trends in Growth, Market Segmentation, and Competitor Approaches Influencing the …
The alpha glucosidase inhibitors market is poised for significant expansion over the next several years, driven by various technological and therapeutic advancements. This segment is witnessing increasing interest due to its role in diabetes management and related conditions, setting the stage for notable growth through 2030.
Projected Market Value and Growth Prospects for Alpha Glucosidase Inhibitors
The market for alpha glucosidase inhibitors is expected to reach a valuation of $7.05…
Analysis of Key Market Segments Driving the Tubular External Fixation System Ind …
The tubular external fixation system market is positioned for significant advancement over the coming years, driven by technological innovation and rising healare demands. This segment of orthopedic care is becoming increasingly important as it addresses the need for effective fracture stabilization and patient-focused recovery methods. Let's explore the market's size, leading players, growth drivers, trends, and segmentation in detail.
Projected Growth and Market Size of the Tubular External Fixation System Market…
Analysis of Key Market Segments Driving the Alkaloid Based Drugs Market
The alkaloid based drugs sector is set for notable expansion over the coming years as interest in natural-origin pharmaceuticals grows and technological advancements continue. This market is poised to reach $4.8 billion by 2030, supported by ongoing innovations and increasing medical demand. Let's explore the market's size projections, key players, growth drivers, and segmentation to understand its future directions.
Alkaloid Based Drugs Market Size and Growth Outlook Through 2030
The…
Top Players and Competitive Dynamics in the Triple Negative Breast Cancer Market
An in-depth look at the triple negative breast cancer market reveals promising growth potential driven by advancements in treatment options and personalized medicine. As this challenging cancer subtype continues to attract research and development efforts, the market is set to expand significantly over the coming years. Here's a detailed analysis of the market size, key players, emerging trends, and segmentation for triple negative breast cancer.
Projected Growth and Market Size of…
More Releases for Biologics
Biologics Contract Manufacturing Market to Hit US$ 83.47 Billion by 2033 | Top C …
Biologics Contract Manufacturing Market reached US$ 26.03 billion in 2024 and is expected to reach US$ 83.47 billion by 2033, growing at a CAGR of 14.0% during the forecast period 2025-2033.
Download your exclusive sample report today (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/biologics-contract-manufacturing-market?prasad
DataM Intelligence unveils exclusive insights into the Biologics Contract Manufacturing Market 2026, highlighting emerging trends, growth drivers, and key regional opportunities worldwide. The report helps solve critical business challenges by…
Platinum Biologics Highlights Rising Consumer Confusion in the Biologics Market
[Orlando, USA - March 27, 2026] - A growing wave of consumer uncertainty is reshaping how patients and buyers approach the biologics market, particularly in emerging categories such as exosomes. As interest accelerates, so does confusion-driven by inconsistent standards, complex terminology, and a flood of marketing claims that are difficult for non-experts to verify.
Recent observations shared by Platinum Biologics point to a clear behavioral shift: consumers are no longer relying…
Biologics CDMO Services Market is Booming Worldwide | Lonza Group, Catalent, Sam …
The latest study released on the Global Biologics CDMO Services Market by HTF MI Research evaluates market size, trend, and forecast to 2033. The Biologics CDMO Services study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Major…
Global Biologics Contract Manufacturing Market Set to Reach $83.47 Billion by 20 …
Biologics Contract Manufacturing Market reached US$ 26.03 billion in 2024 and is expected to reach US$ 83.47 billion by 2033, growing at a CAGR of 14.0% during the forecast period 2025-2033.
The Biologics Contract Manufacturing market involves outsourcing the production of complex biologic drugs, including vaccines, antibodies, and recombinant proteins. Rising demand for biologics, cost-effective manufacturing, and scalable production drives growth. Technological advancements in cell culture, purification, and quality control enhance…
Advanced Biologics Manufacturing Solutions Market Future Business Opportunities …
The qualitative latest Research report (2025-2032) on the Advanced Biologics Manufacturing Solutions Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/137417
Focused on…
Biologics Market
The "Biologics Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Biologics Market, 2024-2031
Verified Market Research's most recent report, "Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination of the industry…
